The following is an excerpt from OpinionJournal’s “Best of the Web” at WSJ written by the editor, James Taranto.
Everyone Happy–Now That Would Be News
“Pope Canonizes 18th-Century Missionary; Not Everyone Happy”—headline, Associated Press, Sept. 23
Bottom Story of the Day
“No Hate Crime on University of Delaware Campus: Officials”—headline, WCAU-TV website (Philadelphia), Sept. 23
Math Is Hard
“The pharmaceutical company that faced an intense backlash for increasing the price of a parasite drug by more than 4,000% said it will lower the price, but have [sic] not indicated how far the price could drop,” ABC News reports:
Turing Pharmaceuticals CEO Martin Shkreli told ABC News on Tuesday that the company would no longer charge $750 a dose for the drug Daraprim, used to treat parasitic infections. Before Turing acquired the drug, it cost $18 a dose.
“We’ve agreed to lower the price on Daraprim to a point that is more affordable and is able to allow the company to make a profit, but a very small profit,” he told ABC News. “We think these changes will be welcomed.”
Mark our words: After raising the price 4,000%, this greedy capitalist will proceed to lower it by less than 100%.
For more “Best of the Web” click here and look for the “Best of the Web Today” link in the middle column below “Today’s Columnists.”